GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (OTCPK:SHPMF) » Definitions » Shares Buyback Ratio %

SHPMF (Shanghai Pharmaceuticals Holding Co) Shares Buyback Ratio % : -0.04 (As of Dec. 14, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Shanghai Pharmaceuticals Holding Co's current shares buyback ratio was -0.04%.

Shanghai Pharmaceuticals Holding Co Shares Buyback Ratio % Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Shares Buyback Ratio % Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -30.10 -0.16

Shanghai Pharmaceuticals Holding Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -0.01 -0.03

Shanghai Pharmaceuticals Holding Co Shares Buyback Ratio % Calculation

Shanghai Pharmaceuticals Holding Co's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2022 ) - Shares Outstanding (EOP) (A: Dec. 2023 )) / Shares Outstanding (EOP) (A: Dec. 2022 )
=(3697.55 - 3703.3) / 3697.55
=-0.16%

Shanghai Pharmaceuticals Holding Co's Shares Buyback Ratio for the quarter that ended in Sep. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2024 ) - Shares Outstanding (EOP) (A: Sep. 2024 )) / Shares Outstanding (EOP) (A: Jun. 2024 )
=(3703.52 - 3704.61) / 3703.52
=-0.03%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pharmaceuticals Holding Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (OTCPK:SHPMF) » Definitions » Shares Buyback Ratio %
Comparable Companies
SHSE:600332 SHSE:600511 SHSE:600056 SHSE:600739 SZSE:000028 SZSE:000950 SHSE:603368 SZSE:002589 SZSE:002551 MCK COR CAH HSIC HKSE:01099 MIL:AMP XSWX:GALE NZSE:EBO TSE:7459 TSE:2784 ASX:SIG
Traded in Other Exchanges
SHPMY:USA 02607:Hong Kong S1R:Germany 601607:China
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Website
https://www.sphchina.com
Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2023, medical distribution is the largest segment, accounting for 89.8% of total revenue. It also has coverage of 31 provinces and cities nationwide.